Excel Venture dedicates $125M fund to life sciences firms

07/8/2009 | Boston Globe (tiered subscription model), The

Excel Venture Management has unveiled a $125 million fund that it will invest in early- to late-stage life sciences companies. Aileron Therapeutics, which works on "Stapled Peptides" that home in on intracellular protein-protein interactions, is among the three firms that secured financing from the Excel Medical Fund.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT